SCM
CRDF icon

Sterling Capital Management’s Cardiff Oncology CRDF Stock Holding History

Sterling Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.07K Sell
1,276
-1,179
-48% -$2.42K ﹤0.01% 2987
2025
Q4 		$6.9K Buy
2,455
+119
+5% +$276 ﹤0.01% 2775
2025
Q3 		$4.81K Buy
2,336
+1,322
+130% +$3.65K ﹤0.01% 2773
2025
Q2 		$3.19K Buy
1,014
+379
+60% +$1.16K ﹤0.01% 2753
2025
Q1 		$1.99K Sell
635
-200
-24% -$791 ﹤0.01% 2604
2024
Q4 		$3.62K Buy
835
+743
+808% +$2.32K ﹤0.01% 2587
2024
Q3 		$246 Buy
+92
New +$217 ﹤0.01% 3082

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Sterling Capital Management's CRDF Position: Q1 2026 in Review

Sterling Capital Management reduced its Cardiff Oncology (CRDF) stake by 48% in Q1 2026, selling an estimated $2.42K and leaving 1,276 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #2987.

Sterling Capital Management first reported a position in CRDF in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.9K in Q4 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Sterling Capital Management held 1,276 shares of Cardiff Oncology worth $2.07K as of Q1 2026.
  • Sterling Capital Management sold 1,179 Cardiff Oncology shares in Q1 2026, an estimated $2.42K.
  • Cardiff Oncology made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2987 holding.
  • Sterling Capital Management first reported a position in Cardiff Oncology in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Cardiff Oncology position peaked at $6.9K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.